Perioperative medicine & outcomes

The association of withholding or continuing angiotensin‐converting enzyme inhibitors or angiotensin 2 receptor blockers on acute kidney injury after non‐cardiac surgery

AnaesthesiaPublished Retrospective cohort study

Main findingResult — go to the resultOdds ratio 1.16 95% CI 1.08–1.25

Authors' conclusion

Continuing angiotensin-converting enzyme inhibitors or angiotensin 2 receptor blockers 24 h before non-cardiac surgery was associated with intra-operative hypotension and postoperative acute kidney injury.

Study context

Population
Patients prescribed ACE inhibitors or angiotensin 2 receptor blockers undergoing surgery > 1 h under general or spinal anaesthesia, single centre, January 2012 to June 2022
Participants
32,933 patients · 8,631 matched pairs
Exposure
Continued vs Withheld
  • Continuedn = 8,648
  • Withheldn = 24,285reference
Outcome
AKI (creatinine increase ≥ 26.4 μmol.l-1)
Follow-up
First 48 postoperative hours
Methodological detailspropensity-score matched, single-centre
  • Propensity-score matched
  • Single-centre

Main finding

As reported in the abstract

Odds ratio

1.16

95% CI 1.08–1.25

P < 0.001

Events by group

Continued vs Withheld
OR 1.16 (95% CI 1.08–1.25); P < 0.001

Observational data: associations, not effects.

Further findings

Change in creatinine concentration

Continuing drugs independently associated with mean increase in creatinine (p < 0.001)
2.2 μmol.l-1

Change in eGFR

Continuing drugs independently associated with mean decrease in eGFR (p < 0.001)
1.4 ml.min.1.73 m-2

Safety

OutcomeContinuedWithheldOR (95% CI)P value
Intra-operative hypotensionPropensity-matched cohort45%39%1.28 (1.21–1.36)P < 0.001

Original publication

The association of withholding or continuing angiotensin‐converting enzyme inhibitors or angiotensin 2 receptor blockers on acute kidney injury after non‐cardiac surgery. Anaesthesia. Published 13 May 2024. doi:10.1111/anae.16308

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.